Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy
The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
Voltage-gated sodium channels (Na(V)) are critical for initiation of action potentials. Heterozygous loss-of-function mutations in Na(V)1.1 channels cause severe myoclonic epilepsy in infancy (SMEI). Homozygous null Scn1a-/- mice developed ataxia and died on postnatal day (P) 15 but could be sustained to P17.5 with manual feeding. Heterozygous Scn1a+/- mice had spontaneous seizures and sporadic deaths beginning after P21, with a notable dependence on genetic background. Loss of Na(V)1.1 did not change voltage-dependent activation or inactivation of sodium channels in hippocampal neurons. The sodium current density was, however, substantially reduced in inhibitory interneurons of Scn1a+/- and Scn1a-/- mice but not in their excitatory pyramidal neurons. An immunocytochemical survey also showed a specific upregulation of Na(V)1.3 channels in a subset of hippocampal interneurons. Our results indicate that reduced sodium currents in GABAergic inhibitory interneurons in Scn1a+/- heterozygotes may cause the hyperexcitability that leads to epilepsy in patients with SMEI.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, a dominant loss of function mutation in Nav1.1 causes Dravet syndrome, an intractable form of childhood-onset epilepsy that arises from a reduction in Na+ channel density in hippocampal interneurons (1255).”
From Hippocampal GABAergic Inhibitory Interneurons (2017) · cites this paper as [1255]
In the citing paper
“Haploinsufficiency or pathogenic variants of Scn1a cause Dravet Syndrome, a common and intractable form of epileptic encephalopathy characterized by the early onset of seizures17–19.”
From Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans (2020) · cites this paper as [19]
In the citing paper
“As loss of expression of Scn1a is especially associated with PV cIN disfunction15–19”
From Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans (2020) · cites this paper as [19]
Citations
Cites
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., & Roder, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8424 · Cited by 2,329 · cited 1×
“The targeting construct was linearized at the Not I site in the polylinker and was electroporated into R1 embryonic stem cell”
MethodEngel, J. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.10401.x · Cited by 2,251
From Ionic Currents to Molecular Mechanisms
Catterall, W. A. (2000) · Neuron · doi:10.1016/s0896-6273(00)81133-2 · Cited by 2,118 · cited 1×
“dtd" [ ]> Voltage-gated Na + channels in the brain are complexes of a 260-kDa α-subunit in association with auxiliary β-subunits (β1–β4) of 33 to 36 kD”
Self-citationEpileptic Syndromes in Infancy, Childhood and Adolescence
Rogers, J., Bureau, M., Dravet, C., Dreifuss, F. E., Perret, A., Wolf, P., & Armstrong, D. L. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199307000-00012 · Cited by 1,470
De Novo Mutations in the Sodium-Channel Gene SCN1A Cause Severe Myoclonic Epilepsy of Infancy
Claes, L., Del-Favero, J., Ceulemans, B., Lagae, L., Van Broeckhoven, C., & De Jonghe, P. (2001) · The American Journal of Human Genetics · doi:10.1086/320609 · Cited by 1,292
(2005) · Cited by 944
Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy
de Lanerolle, N. C., Kim, J. H., Robbins, R. J., & Spencer, D. D. (1989) · Brain Research · doi:10.1016/0006-8993(89)90234-5 · Cited by 927
Buhl, E. H., Halasy, K., & Somogyi, P. (1994) · Nature · doi:10.1038/368823a0 · Cited by 728
Overview of the voltage-gated sodium channel family
Yu (2003) · Genome biology · doi:10.1186/gb-2003-4-3-207 · Cited by 694 · cited 1×
“dtd" [ ]> Voltage-gated Na + channels in the brain are complexes of a 260-kDa α-subunit in association with auxiliary β-subunits (β1–β4) of 33 to 36 kD”
Sodium channel Na v 1.6 is localized at nodes of Ranvier, dendrites, and synapses
Caldwell, J. H., Schaller, K. L., Lasher, R. S., Peles, E., & Levinson, S. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090034797 · Cited by 649 · cited 1×
“6 is localized in dendrites and in the nodes of Ranvie”
Background
Cited by
Items 601–700 of 1,000
Seizure reduction with fluoxetine in an adult woman with Dravet syndrome
Meador, K. J. (2014) · Epilepsy & Behavior Case Reports · doi:10.1016/j.ebcr.2014.03.001 · Cited by 17
“Animal models exhibit the characteristic temperature/age dependent seizures seen in humans, and there is a 50% reduction in sodium current in heterozygous SCN1Amutations [10].”
BackgroundOhmori, I., Kawakami, N., Liu, S., Wang, H., Miyazaki, I., Asanuma, M., Michiue, H., Matsui, H., Mashimo, T., & Ouchida, M. (2014) · Epilepsia · doi:10.1111/epi.12750 · Cited by 19
“1,2,15 Indeed, anticonvulsants such as valproic acid, benzodiazepines, and potassium bromide — drugs that enhance GABA-mediated inhibition — were effective in Dravet syndrome patients with SCN1A mutations.”
BackgroundIon Channels in Epilepsy: Blasting Fuse for Neuronal Hyperexcitability
Zhang, S., Zhu, Y., Cheng, J., & Tao, J. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.83698 · Cited by 19
Chuang, S.-H., Westenbroek, R. E., Stella, N., & Catterall, W. A. (2021) · Journal of Experimental Neurology · doi:10.33696/neurol.2.040 · Cited by 17
“Using a well-established Scn1a+/− mouse model of DS [10], we found that low-dose CLZ improves impaired social interaction and contextual learning without sedative side effects [11].”
Self-citationClinical Trial Design for Disease-Modifying Therapies for Genetic Epilepsies
Brock, D. C., Demarest, S., & Benke, T. A. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01123-5 · Cited by 18
“Dravet models offer reasonable face validity with regard to epilepsy, displaying both ictal and interictal activities, as well as myoclonic jerks and flexions [22].”
BackgroundVolkers, L., Kahlig, K. M., Das, J. H. G., van Kempen, M. J. A., Lindhout, D., Koeleman, B. P. C., & Rook, M. B. (2013) · The Journal of General Physiology · doi:10.1085/jgp.201311042 · Cited by 19
“A DS-like phenotype can be caused by decreased sodium currents in GABAergic inhibitory interneurons, as shown in Scn1a+/ DS mouse models (Yu et al., 2006; Ogiwara et al., 2007).”
BackgroundInfluentialDravet Variant SCN1AA1783V Impairs Interneuron Firing Predominantly by Altered Channel Activation
Layer, N., Sonnenberg, L., González, E. P., Benda, J., Hedrich, U. B. S., Lerche, H., Koch, H., & Wuttke, T. V. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.754530 · Cited by 18
Doorn, N., van Hugte, E., Ciptasari, U., Mordelt, A., Meijer, H. G. E., Schubert, D., Frega, M., Kasri, N. N., & van Putten, M. J. A. M. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.06.003 · Cited by 18
Toward the use of novel alternative methods in epilepsy modeling and drug discovery
Sanz, C. M., Navarro, M. M., Diaz, D. C., Sánchez‐Elexpuru, G., & Donato, V. D. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1213969 · Cited by 18
Sugiura, Y., Ogiwara, I., Hoshi, A., Yamakawa, K., & Ugawa, Y. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03467.x · Cited by 16
“Moreover, action potentials were abnormally reduced in c-aminobutyric acid (GABA)ergic inhibitory interneurons in SCN1A mutant mice (Yu et al., 2006; Ogiwara et al., 2007).”
BackgroundNew therapeutic opportunities in epilepsy: A genetic perspective
Reid, C. A., Jackson, G. D., Berkovic, S. F., & Petrou, S. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.07.003 · Cited by 16
Mutation spectrum of the SCN1A gene in a Hungarian population with epilepsy
Till, Á., Zima, J., Fekete, A., Bene, J., Czakó, M., Szabó, A., Melegh, B., & Hadzsiev, K. (2019) · Seizure · doi:10.1016/j.seizure.2019.10.019 · Cited by 17
SCN8A Encephalopathy: Case Report and Literature Review
Fan, H., Lee, H.-F., & Chi, C. (2021) · Neurology International · doi:10.3390/neurolint13020014 · Cited by 16
Liu, Y.-H., Cheng, Y.-T., Tsai, M., Chou, I., Hung, P., Hsieh, M., Wang, Y., Chen, Y., Kuo, C., Lin, J., et al. (2021) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2021.05.022 · Cited by 16
Almog, Y., Mavashov, A., Brusel, M., & Rubinstein, M. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.823640 · Cited by 17
Ryner, R. F., Derera, I. D., Armbruster, M., Kansara, A., Sommer, M., Pirone, A., Noubary, F., Jacob, M. H., & Dulla, C. G. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0572-22.2022 · Cited by 17
“…constraint of cortical circuits and are critical in developmental cortical circuit refinement (Freund and Buzsáki, 1998; Buzsáki, 2006; Klausberger and Somogyi, 2008), and GABAergic circuit dysfunction is implicated in epilepsy and IESS (F. H. Yu et al., 2006; Price et al., 2009; Khazipov, 2016).”
BackgroundFoyaca-Sibat, H. (2011) · InTech eBooks · doi:10.5772/1137 · Cited by 16
Why Are Children With Epileptic Encephalopathies Encephalopathic?
Barry, J. M., & Holmes, G. L. (2016) · Journal of Child Neurology · doi:10.1177/0883073816662140 · Cited by 17
Lin, G., Lu, P., Zeng, T., Tang, H.-L., Chen, Y., Liu, S., Gao, M., Zhao, Q.-H., Yi, Y., & Long, Y. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.11.002 · Cited by 16
“These mutations likely lead to a haploinsufficiency effect, which has been confirmed in Scn1aþ/- mice with epileptic seizures (Cheah et al., 2012; Yu et al., 2006).”
Williams, A. D., Kalume, F. K., Westenbroek, R. E., & Catterall, W. A. (2019) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2019.108315 · Cited by 17
“The severe nature of the DS phenotype means that fewer than 60% of mice heterozygous for the global Scn1a+/− mutation survive to breeding age, requiring the maintenance of a large breeding stock to sustain a viable colony (Kalume et al., 2013; Yu et al., 2006).”
BackgroundSelf-citationPathophysiological Mechanisms of Seizures and Epilepsy: A Primer
Stafstrom, C. E. (2010) · Epilepsy · doi:10.1201/9781420085594-c1 · Cited by 26
A hot topic: Temperature sensitive sodium channelopathies
Egri, C., & Ruben, P. C. (2012) · Channels · doi:10.4161/chan.19827 · Cited by 19
Thouta, S., Waldbrook, M., Lin, S., Mahadevan, A., Mezeyova, J., Soriano, M., Versi, P., Goodchild, S. J., & Parrish, R. R. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.964691 · Cited by 16
Zayat, V., Kuczynska, Z., Liput, M., Metin, E., Rzońca, S., Smyk, M., Mazurczak, T., Goszczańska‐Ciuchta, A., Leszczyński, P., Hoffman‐Zacharska, D., et al. (2023) · Cells · doi:10.3390/cells12020339 · Cited by 19
“The results revealed impairments in action potential generation in response to sustained current injection, confirming previous studies from in vitro rodent epilepsy models with SCN1A mutation [8,9].”
BackgroundResultA hyperthermic seizure unleashes a surge of spreading depolarizations in Scn1a-deficient mice
Aiba, I., Ning, Y. Y., & Noebels, J. L. (2023) · JCI Insight · doi:10.1172/jci.insight.170399 · Cited by 18
Integrative analysis of epilepsy-associated genes reveals expression-phenotype correlations
Chi, W., & Kiskinis, E. (2024) · Scientific Reports · doi:10.1038/s41598-024-53494-2 · Cited by 19
Early developmental alterations of CA1 pyramidal cells in Dravet syndrome
Jones, S. P., O’Neill, N., Carpenter, J. C., Muggeo, S., Colasante, G., Kullmann, D. M., & Lignani, G. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106688 · Cited by 18
“Interneuron excitability has not been demonstrated to be affected by Scn1a hemizygosity until P16 – 20, immediately prior to the emergence of seizures (Yu et al., 2006; Favero et al., 2018; Almog et al., 2021; Kaneko et al., 2022).”
BackgroundInfluentialCiampa, E. J., Kunic, J. D., & George, A. L. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32448 · Cited by 15
“These findings suggest that haploinsufficiency is a plausible mechanism to explain thedisease and this idea is consistentwith the observations that mice heterozygous for either a null or truncated Scn1a allele exhibit a severe seizure phenotype [Yu et al., 2006; Ogiwara et al., 2007].”
ResultWONOEP appraisal: New genetic approaches to study epilepsy
Rossignol, E., Kobow, K., Simonato, M., Loeb, J. A., Grisar, T. M., Gilby, K. L., Vinet, J., Kadam, S. D., & Becker, A. J. (2014) · Epilepsia · doi:10.1111/epi.12692 · Cited by 19
Liavas, A., Lignani, G., & Schorge, S. (2017) · The Journal of Physiology · doi:10.1113/jp274693 · Cited by 15
“…allow more rapid firing of neurons in the face of intense synaptic excitation, which given the predominant location of this channel in interneurons (Yu et al. 2006; Ogiwara et al. 2007), could help protect against seizure activity, but even if this is the case, this protection does not appear…”
BackgroundTan, Y., Liu, G., Chen, H.-L., Lu, M., Chen, B., Hu, T., Zhang, L., Mao, R., Li, S., Mei, R., et al. (2020) · Neural Plasticity · doi:10.1155/2020/9132720 · Cited by 17
“1 is primarily localized to the neuronal soma [17, 18], while Nav1.”
BackgroundPossible interplay between the theories of pharmacoresistant epilepsy
Juvale, I. I. A., & Has, A. T. C. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.15079 · Cited by 17
Uchino, K., Kawano, H., Tanaka, Y., Adaniya, Y., Asahara, A., Deshimaru, M., Kubota, K., Watanabe, T., Katsurabayashi, S., Iwasaki, K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-90224-4 · Cited by 18
Perampanel Reduces Hyperthermia-Induced Seizures in Dravet Syndrome Mouse Model
Ho, S., Lin, L., Chen, I., Tsai, C., Chang, F., & Liou, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.682767 · Cited by 15
“Previous work in our and other laboratories supports the hypothesis that the mechanism of epileptogenesis in Dravet syndrome is insufficient GABA release leading to brain hyperexcitability (Yu et al., 2006; Ogiwara et al., 2007; Tsai et al., 2015).”
ResultFibroblast growth factor 13 is involved in the pathogenesis of temporal lobe epilepsy
Shen, K., Yue, J., Wu, Z., Wu, K., Zhu, G., Yang, X.-L., Wang, Z.-K., Wang, J., Liu, S., Yang, H., et al. (2022) · Cerebral Cortex · doi:10.1093/cercor/bhac012 · Cited by 16
Santos‐Terra, J., Deckmann, I., Carello‐Collar, G., Nunes, G. D., Bauer‐Negrini, G., Schwingel, G. B., Fontes‐Dutra, M., Riesgo, R. D. S., & Gottfried, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084075 · Cited by 20
Tian, F., Cao, B., Xu, H., Zhan, L., Nan, F., Li, N., Taglialatela, M., & Gao, Z. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105860 · Cited by 15
Ghovanloo, M., Dib‐Hajj, S. D., Goodchild, S. J., Ruben, P. C., & Waxman, S. G. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1066455 · Cited by 21
Calmodulin and calcium differentially regulate the neuronal Nav1.1 voltage-dependent sodium channel
Gaudioso, C., Carlier, E., Youssouf, F., Clare, J. J., Debanne, D., & Alcaraz, G. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.142 · Cited by 17
Musicogenic seizures in D ravet syndrome
Sánchez-Carpintero, R., Patiño‐García, A., & Urrestarazu, E. (2013) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.12138 · Cited by 14
“In recent years, animal models based on alterations in the SCN1A gene have been developed and have led to a better understanding of the biochemical and neurophysiological bases of the clinical phenotype.(5) The most common precipitant of reflex seizures in Dravet syndrome is fever; less frequent precipitants are inter…”
BackgroundKano, S., Yuan, M., Cardarelli, R. A., Maegawa, G. H. B., Higurashi, N., Gaval‐Cruz, M., Wilson, A. M., Tristan, C., Kondo, M., Chen, Y., et al. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150303110300 · Cited by 15
“Thus, mouse genetic models such as SCN1A knockout mice currently indicated that the mutation mainly affects GABAergic interneurons, and less attention was paid to any pathological changes in glutamatergic neurons [26, 27].”
BackgroundTang, L., Wang, Y., Leng, T., Sun, H., Zhou, Y., Zhu, W., Qiu, P., Zhang, J., Lu, B., Yan, M., et al. (2015) · Steroids · doi:10.1016/j.steroids.2014.12.025 · Cited by 16
Caplan, R., Mefford, H. C., Berl, M. M., Chang, B. S., Lin, J. J., Mazarati, A. M., Fureman, B. E., & Dingledine, R. J. (2016) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7511-16.3.182 · Cited by 16
Autistic traits in epilepsy models: Why, when and how?
Velíšková, J., Silverman, J. L., Benson, M. J., & Lenck‐Santini, P. (2018) · Epilepsy Research · doi:10.1016/j.eplepsyres.2018.05.009 · Cited by 16
Yu, F. H., Mantegazza, M., Westenbroek, R. E., Robbins, C. A., Kalume, F. K., Burton, K. A., Spain, W. J., McKnight, G. S., Scheuer, T., & Catterall, W. A. (2006) · Nature Neuroscience · doi:10.1038/nn0107-134b · Cited by 15
Self-citationZhan, R.-Z., Nadler, J. V., & Schwartz-Bloom, R. D. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600448 · Cited by 14
“Recently, functional deletion of the gene that encodes Na v 1.1 was shown to reduce Na + current density in hippocampal interneurons, but not in pyramidal cells (Yu et al, 2006).”
InfluentialAction Potentials Are Critical for the Propagation of Focally Elicited Spreading Depolarizations
Suryavanshi, P. S., Reinhart, K. M., Shuttleworth, C. W., & Brennan, K. C. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2930-20.2021 · Cited by 18
Ricobaraza, A., Buñuales, M., González-Aparicio, M., Fadila, S., Rubinstein, M., Vides-Urrestarazu, I., Banderas, J., Sola-Sevilla, N., Sánchez-Carpintero, R., Lanciego, J. L., et al. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02383-8 · Cited by 15
“Results obtained in mouse models indicate that SCN1A haploinsufficiency impairs the function of GABAergic interneurons [9–13].”
BackgroundTsien, R. W., & Rosenberg, E. C. (2025) · Molecular Pharmacology · doi:10.1016/j.molpha.2025.100017 · Cited by 15
“( B1, B2) Conditional deletion of Scn1a in forebrain interneurons (F/ þ :Dlx-Cre þ , white triangles) is suf fi cient to lower the threshold for thermally induced seizures (B1) (Cheah et al, 2012).”
InfluentialDravet syndrome: Insights from in vitro experimental models
Mantegazza, M. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03005.x · Cited by 14
“Na+ currents have been studied initially in this model by recording from acutely dissociated hippocampal neurons (Yu et al., 2006).”
BackgroundSelf-citationKim, D., Yeon, C., & Kim, K. (2017) · Sensors · doi:10.3390/s17020326 · Cited by 14
Perulli, M., Battista, A., Sivo, S., Turrini, I., Musto, E., Quintiliani, M., Gambardella, M. L., Contaldo, I., Veredice, C., Mercuri, E. M., et al. (2021) · Seizure · doi:10.1016/j.seizure.2021.11.023 · Cited by 14
Anderson, L. L., Udoh, M., Everett‐Morgan, D., Heblinski, M., McGregor, I. S., Banister, S. D., & Arnold, J. C. (2022) · Journal of Cannabis Research · doi:10.1186/s42238-021-00113-w · Cited by 20
Chancey, J. H., & Howard, M. A. (2022) · eNeuro · doi:10.1523/eneuro.0080-22.2022 · Cited by 14
“While mortality is at its peak in the earlier period correlating with greatest interneuron dysfunction, seizures and other deficits persist even in Het mice that survive long into adulthood (Yu et al., 2006; Han et al., 2012; Kalume et al., 2013).”
BackgroundResultInfluentialAstrocytic Glutamate Transporters and Migraine
Conti, F., & Pietrobon, D. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03849-w · Cited by 14
Cha, J., Filatov, G., Smith, S. J., Gammaitoni, A. R., Lothe, A., & Reeder, T. (2023) · Epilepsia Open · doi:10.1002/epi4.12873 · Cited by 14
“30,31 Conditional knockout and knockdown studies in DS models suggest that nonseizure comorbidities may occur as primary consequences of the Scn1a mutation in addition to secondary consequences of seizure burden, 32–40 confirming clinical reports.”
BackgroundAcupuncture Treatment of Epilepsy
Chao, D., & Xia, Y. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3357-6_6 · Cited by 18
Lutz, N. W., Béraud, E., & Cozzone, P. J. (2014) · Journal of Visualized Experiments · doi:10.3791/51829 · Cited by 14
Ion Channels and Their Inhibitors
Gupta, S. P. (2011) · Springer eBooks · doi:10.1007/978-3-642-19922-6 · Cited by 18
Haginoya, K., Togashi, N., Kaneta, T., Hino‐Fukuyo, N., Ishitobi, M., Kakisaka, Y., Uematsu, M., Inui, T., Okubo, Y., Sato, R., et al. (2018) · Epilepsy Research · doi:10.1016/j.eplepsyres.2018.08.008 · Cited by 15
Rodent genetic models of neurodevelopmental disorders and epilepsy
Gonzalez‐Sulser, A. (2019) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2019.12.012 · Cited by 18
Dyment, D. A., Schock, S., Deloughery, K., Tran, M. H., Ure, K., Nutter, L. M. J., Creighton, A., Yuan, J. S., Banderali, U., Comas, T., et al. (2020) · Genetics · doi:10.1534/genetics.120.303399 · Cited by 15
Chang, B. S., Krishnan, V., Dulla, C. G., Jetté, N., Marsh, E. D., Dacks, P. A., Whittemore, V., & Poduri, A. (2020) · Epiliepsy currents/Epilepsy currents · doi:10.1177/1535759719895280 · Cited by 16
Holtkamp, D., Opitz, T., Hebeisen, S., Soares-da-Silva, P., & Beck, H. (2018) · Epilepsia · doi:10.1111/epi.14504 · Cited by 14
Genetic influences on ketogenic diet efficacy
Dutton, S. B. B., & Escayg, A. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01839.x · Cited by 15
“gene (Ogiwara et al., 2007; Yu et al., 2006), the genetic variation observed in the human population could be mod-”
SCN2A and Its Related Epileptic Phenotypes
Praticò, A. D., Giallongo, A., Arrabito, M., D'Amico, S., Gauci, M. C., Lombardo, G., Polizzi, A., Falsaperla, R., & Ruggieri, M. (2021) · Journal of Pediatric Neurology · doi:10.1055/s-0041-1727097 · Cited by 13
Thomas, C. F., Hawkins, D. Y., Skidanova, V., Marrujo, S. R., Gibson, J., Ye, Z., & Bradham, C. A. (2023) · Development · doi:10.1242/dev.201460 · Cited by 13
A review of the putative antiseizure and antiepileptogenic mechanisms of action for soticlestat
Kondo, S., Murthy, N. V., Asgharnejad, M., Benitez, A., Nakashima, K., Hawkins, N. A., & White, H. S. (2025) · Epilepsia · doi:10.1111/epi.18287 · Cited by 13
“63 Soticlestat treatment reduced seizure burden to almost zero, completely prevented premature lethality, and increased the temperature threshold for heat-induced seizures in two distinct Scn1a Dravet mouse models.”
Yu, S., Li, S., Shu, H., Zhang, C., He, J., Fan, X., & Yang, H. (2012) · Neuroreport · doi:10.1097/wnr.0b013e328351db48 · Cited by 13
Shibata, A., Kasai, M., Terashima, H., Hoshino, A., Miyagawa, T., Kikuchi, K., Ishii, A., Matsumoto, H., Kubota, M., Hirose, S., et al. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116808 · Cited by 13
Silvennoinen, K., Balestrini, S., Rothwell, J. C., & Sisodiya, S. M. (2020) · Epilepsia · doi:10.1111/epi.16634 · Cited by 14
Current Pharmacologic Strategies for Treatment of Intractable Epilepsy in Children
Moon, J. U., & Cho, K. (2021) · International Neurourology Journal · doi:10.5213/inj.2142166.083 · Cited by 13
“1 (especially in GABAergic-inhibitory neurons) leads to hyperexcitability of excitatory neurons due to deficits in action potential firing of the interneurons, which is known as the “interneuron hypothesis” [24-26].”
BackgroundAutonomic dysfunction in epilepsy mouse models with implications for SUDEP research
Bauer, J., Devinsky, O., Rothermel, M., & Koch, H. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2022.1040648 · Cited by 16
Koch, N. A., Sonnenberg, L., Hedrich, U. B. S., Lauxmann, S., & Benda, J. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1194811 · Cited by 15
“SCN1A (34–36); however, limited success in the treatment of Dravet syndrome persisted (34, 37) in part due to the lack of understanding that inhibitory interneurons and not pyramidal neurons had altered excitability as a result of LOF SCN1Amutations (15, 16).”
BackgroundA novel rat model of Dravet syndrome recapitulates clinical hallmarks
Li, M., Yang, L., Qian, W., Ray, S., Lu, Z., Liu, T., Zou, Y., Naumann, R. K., & Wang, H. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106193 · Cited by 14
Temporal manipulation of the Scn1a gene reveals its essential role in adult brain function
Berardino, C. D., Mainardi, M., Brusco, S., Benvenuto, E., Broccoli, V., & Colasante, G. (2023) · Brain · doi:10.1093/brain/awad350 · Cited by 14
“Na v 1.1 is mainly expressed in GABAergic interneurons with higher levels in PV subtypes 19,23,27 and its haploinsufficiency is well known to induce a dramatic, although transient, impairment in their excitability.”
BackgroundInfluentialInduced pluripotent stem cells for modeling of pediatric neurological disorders
Jang, J., Quan, Z., Yum, Y. J., Song, H. S., Paek, S., & Kang, H. (2014) · Biotechnology Journal · doi:10.1002/biot.201400010 · Cited by 16
“Interestingly, a mutated SCN1A gene results in either a gain or loss of function in the sodium channel, and the outcomes of each are still under the investigation [80, 81].”
BackgroundSCN1A mutational analysis in Korean patients with Dravet syndrome
Lim, B. C., Hwang, H. Y., Chae, J., Choi, J. E., Hwang, Y. S., Kang, S.-H., Ki, C., & Kim, K. J. (2011) · Seizure · doi:10.1016/j.seizure.2011.08.002 · Cited by 13
“002 mutation.(4,5) Truncating (nonsense and frameshift) and missense mutations are the major mutation types in Dravet syndrome and their relative frequency in patients with this disease was estimated as being roughly similar to that reported in the large SCN1A database.”
ResultGenetic and phenotypic characteristics of SCN1A-related epilepsy in Chinese children
Fang, Z., Hong, S., Li, T.-S., Wang, J., Xie, L., Han, W., & Jiang, L. (2019) · Neuroreport · doi:10.1097/wnr.0000000000001259 · Cited by 14
Exploring the molecular basis of neuronal excitability in a vocal learner
Friedrich, S. R., Lovell, P. V., Kaser, T., & Mello, C. V. (2019) · BMC Genomics · doi:10.1186/s12864-019-5871-2 · Cited by 14
Qu, S., Zhou, C., Howe, R., Shen, W., Huang, X., Catron, M. A., Hu, N., & Macdonald, R. L. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105296 · Cited by 13
Molecular basis of severe myoclonic epilepsy in infancy
Yamakawa, K. (2009) · Brain and Development · doi:10.1016/j.braindev.2008.11.015 · Cited by 14
“[40] Yu FH, Mantegazza M, Westenbroek RE, Robbins CA, Kalume F, Burton KA, et al.”
AVANZINI, G., & Franceschetti, S. (2009) · Wiley eBooks · doi:10.1002/9781444316667.ch5 · Cited by 14
PROGRESS and FUTURE DIRECTIONS
Poland, T. M. (2014) · Cited by 13
Terragni, B., Scalmani, P., Colombo, E., Franceschetti, S., & Mantegazza, M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.06.029 · Cited by 12
Self-citationAlterations of Neuronal Dynamics as a Mechanism for Cognitive Impairment in Epilepsy
Lenck‐Santini, P., & Sakkaki, S. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_193 · Cited by 15
Tapia, A., Giachello, C. N., Palomino‐Schätzlein, M., Baines, R., & Galindo, M. I. (2021) · Life · doi:10.3390/life11111261 · Cited by 14
Clocking Epilepsies: A Chronomodulated Strategy-Based Therapy for Rhythmic Seizures
Sun, S., & Wang, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044223 · Cited by 13
Hippocampal interneuronal dysfunction and hyperexcitability in a porcine model of concussion
Ulyanova, A. V., Adam, C. D., Cottone, C., Maheshwari, N., Grovola, M. R., Fruchet, O., Alamar, J., Koch, P. F., Johnson, V. E., Cullen, D. K., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05491-w · Cited by 12
Verpelli, C., Galimberti, I., Gomez‐Mancilla, B., & Sala, C. (2013) · Developmental Neurobiology · doi:10.1002/dneu.22093 · Cited by 15
“1 is the primary Na1 channel in those cells (Yu et al., 2006).”
BackgroundHatch, R. J., Reid, C. A., & Petrou, S. (2014) · Epilepsia · doi:10.1111/epi.12568 · Cited by 12
DEPDC5 takes a second hit in familial focal epilepsy
Anderson, M. P. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121052 · Cited by 13
“This study provides important insights into familial focal epilepsy and provides a preclinical model for evaluating potential therapies. evidence of somatic mutations of SCN1A and other genes in autism-epilepsy comorbidity disorders (17, 18).”
Morris, G., Rowell, R., & Cunningham, M. O. (2021) · ALTEX · doi:10.14573/altex.2007082 · Cited by 17
“Using this clinical knowledge, multiple mouse models of Dravet syndrome have been developed (Yu et al., 2006; Ogiwara et al., 2007; Miller et al., 2014), and it has been demonstrated that Scn1a+/- mice exhibit both spontaneous and hyperthermia-induced seizures”
BackgroundMechanisms underlying CSD initiation implicated by genetic mouse models of migraine
Pietrobon, D., & Brennan, K. C. (2025) · The Journal of Headache and Pain · doi:10.1186/s10194-025-01948-x · Cited by 12
Bleakley, L. E., McKenzie, C. E., & Reid, C. A. (2022) · Epilepsia · doi:10.1111/epi.17447 · Cited by 11
SCN1A as a therapeutic target for Dravet syndrome
Myers, K. A. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2230364 · Cited by 11
“1 function leads to decreased sodium current primarily in inhibitory GABAergic interneurons, while excitatory cells are relatively unaffected [10].”
BackgroundAltered PKA modulation in the Nav1.1 epilepsy variant I1656M
Liu, S., & Zheng, P. (2013) · Journal of Neurophysiology · doi:10.1152/jn.00921.2012 · Cited by 11
“1 deletion appeared only to have an effect on total sodium currents in interneurons (Kalume et al. 2007; Yu et al. 2006).”
InfluentialThe impact of genetic and experimental studies on classification and therapy of the epilepsies
AVANZINI, G., Mantegazza, M., Terragni, B., Canafoglia, L., Scalmani, P., & Franceschetti, S. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.05.026 · Cited by 12
Self-citationEpileptic Encephalopathies as Neurodegenerative Disorders
Helbig, I., von Deimling, M., & Marsh, E. D. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-57193-5_11 · Cited by 15
Rational Small Molecule Treatment for Genetic Epilepsies
Goldberg, E. M. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01110-w · Cited by 14
Metadata
- Authors
- Yu, F. H., Mantegazza, M., Westenbroek, R. E., Robbins, C. A., Kalume, F., Burton, K. A., Spain, W. J., McKnight, G. S., Scheuer, T., & Catterall, W. A.
- Affiliations
- University of Washington (US)
- Corresponding author
- Catterall, William A
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2006-08-20
- Volume
- 9
- Issue
- 9
- Pages
- 1142-1149
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2105423985
- Cited by
- 1,173
- References
- 55
- Citations by year
- 2026: 54 · 2025: 72 · 2024: 66 · 2023: 69 · 2022: 73 · 2021: 85 · 2020: 70 · 2019: 70 · 2018: 53 · 2017: 59 · 2016: 47 · 2015: 63 · 2014: 64 · 2013: 64 · 2012: 52
- FWCI
- 22.30
- Type
- journal article
- Language
- en
- Update notices
- erratum (2007-01-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- Dravet syndrome, SCN1A, Nav1.3, GABAergic interneurons, sodium current, hippocampus, neuronal hyperexcitability, epilepsy, genetic background effects
- MeSH terms
- Action Potentials, Animals, Cell Line, Disease Models, Animal, Electroencephalography, Epilepsies, Myoclonic, gamma-Aminobutyric Acid, Genotype, Humans, Infant, Interneurons, Mice, Inbred C57BL, Mice, Inbred Strains, Mutation, Nerve Tissue Proteins, Phenotype, Seizures, Immunoblotting, Sodium Channels, Survival Rate, Mice, Knockout, Patch-Clamp Techniques, Mice, NAV1.1 Voltage-Gated Sodium Channel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.